🇺🇸 FDA
Patent

US 11760794

Neutralizing antibodies to plasmodium falciparum circumsporozoite protein and their use

granted A61PA61P33/06

Quick answer

US patent 11760794 (Neutralizing antibodies to plasmodium falciparum circumsporozoite protein and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P33/06